About Us
Company Overview
Our Leadership
Global Supply Chain
IP Protection
Quality & Compliance
Environmental, Health and Safety
Solutions and Services
Discovery Synthesis
GMP Services
Generic APIs
FTE Services
Regulatory Affairs
Peptide Synthesis Service
Oligonucleotide Synthesis
Cosmetic Peptides
GMP Manufacturing
GMP Production Capacity
GMP Compliance & Certification
Leuprorelin Acetate
Triptorelin Acetate
Triptorelin Pamoate
Goserelin Acetate
Cetrorelix Acetate
Exenatide Acetate
Semaglutide
Terlipressin Acetate
Teduglutide
Linaclotide
Difelikefalin
Resources Center
FAQ
White Paper
Video
News
Company News
Blog
Careers
Contact Us
Catalog Peptides
US Operation
WHAT ARE YOU LOOKING FOR?
Home
About Us
About Us
Company Overview
Our Leadership
Global Supply Chain
IP Protection
Quality & Compliance
Environmental, Health and Safety
Solutions and Services
Solutions and Services
Discovery Synthesis
GMP Services
Generic APIs
FTE Services
Regulatory Affairs
Resources Center
Resources Center
FAQ
White Paper
Video
News
News
Company News
Blog
Careers
Contact Us
Catalog Peptides
US Operation
Email Us
Search
Search
Home
Catalog Peptides
p53 Peptides
p53 Peptides
CANC-002A
[Lys(Ac)373]-p53 (368-393), p53 K373(Ac), biotin-labeled, human
Biotin-Lys-Gly-Gly-His-Leu-Lys-Ser-Lys-Lys(Ac)-Gly-Gln-Ser-Thr-Ser-Arg-His-Lys-Lys-Leu-Met-Phe-Lys-Thr-Glu-Gly-Pro-Asp-Ser-Asp-NH2
CANC-002B
[Lys(Ac)373]-p53 (368-393), p53 K373(Ac), biotin-labeled, human
Biotin-Lys-Gly-Gly-His-Leu-Lys-Ser-Lys-Lys(Ac)-Gly-Gln-Ser-Thr-Ser-Arg-His-Lys-Lys-Leu-Met-Phe-Lys-Thr-Glu-Gly-Pro-Asp-Ser-Asp-NH2
CANC-003A
[Lys(Ac)373]-p53 (368-393), p53 K373(Ac), biotin-labeled, human
Biotin-Lys-Gly-Trp-His-Leu-Lys-Ser-Lys-Lys(Ac)-Gly-Gln-Ser-Thr-Ser-Arg-His-Lys-Lys-Leu-Met-Phe-Lys-Thr-Glu-Gly-Pro-Asp-Ser-Asp-NH2
CANC-003B
[Lys(Ac)373]-p53 (368-393), p53 K373(Ac), biotin-labeled, human
Biotin-Lys-Gly-Trp-His-Leu-Lys-Ser-Lys-Lys(Ac)-Gly-Gln-Ser-Thr-Ser-Arg-His-Lys-Lys-Leu-Met-Phe-Lys-Thr-Glu-Gly-Pro-Asp-Ser-Asp-NH2
CANC-004A
[Lys(Ac)382]-p53 (361-393), biotin labeled, amide, human
Biotin-C6-Gly-Ser-Arg-Ala-His-Ser-Ser-His-Leu-Lys-Ser-Lys-Lys-Gly-Gln-Ser-Thr-Ser-Arg-His-Lys-Lys(Ac)-Leu-Met-Phe-Lys-Thr-Glu-Gly-Pro-Asp-Ser-Asp-NH2
CANC-004B
[Lys(Ac)382]-p53 (361-393), biotin labeled, amide, human
Biotin-C6-Gly-Ser-Arg-Ala-His-Ser-Ser-His-Leu-Lys-Ser-Lys-Lys-Gly-Gln-Ser-Thr-Ser-Arg-His-Lys-Lys(Ac)-Leu-Met-Phe-Lys-Thr-Glu-Gly-Pro-Asp-Ser-Asp-NH2
CANC-005A
[Lys(Ac)382]-p53 (368-393), p53 K382(Ac), biotin-labeled, human
Biotin-Lys-Gly-Gly-His-Leu-Lys-Ser-Lys-Lys-Gly-Gln-Ser-Thr-Ser-Arg-His-Lys-Lys(Ac)-Leu-Met-Phe-Lys-Thr-Glu-Gly-Pro-Asp-Ser-Asp-NH2
CANC-005B
[Lys(Ac)382]-p53 (368-393), p53 K382(Ac), biotin-labeled, human
Biotin-Lys-Gly-Gly-His-Leu-Lys-Ser-Lys-Lys-Gly-Gln-Ser-Thr-Ser-Arg-His-Lys-Lys(Ac)-Leu-Met-Phe-Lys-Thr-Glu-Gly-Pro-Asp-Ser-Asp-NH2
CANC-006A
[Lys(Ac)382]-p53 (372-389), biotin labeled
Biotin-LC-Lys-Lys-Gly-Gln-Ser-Thr-Ser-Arg-His-Lys-Lys(Ac)-Leu-Met-Phe-Lys-Thr-Glu-Gly
CANC-006B
[Lys(Ac)382]-p53 (372-389), biotin labeled
Biotin-LC-Lys-Lys-Gly-Gln-Ser-Thr-Ser-Arg-His-Lys-Lys(Ac)-Leu-Met-Phe-Lys-Thr-Glu-Gly
CANC-007A
[Lys(Ac)382]-p53 (372-389), biotin labeled, amide
Biotin-LC-Lys-Lys-Gly-Gln-Ser-Thr-Ser-Arg-His-Lys-Lys(Ac)-Leu-Met-Phe-Lys-Thr-Glu-Gly-NH2
CANC-007B
[Lys(Ac)382]-p53 (372-389), biotin labeled, amide
Biotin-LC-Lys-Lys-Gly-Gln-Ser-Thr-Ser-Arg-His-Lys-Lys(Ac)-Leu-Met-Phe-Lys-Thr-Glu-Gly-NH2
CANC-008A
[Lys(Ac)382]-p53 (374-389); p53 acetylated K382
Ac-Gly-Gln-Ser-Thr-Ser-Arg-His-Lys-Lys(Ac)-Leu-Met-Phe-Lys-Thr-Glu-Gly-NH2
CANC-009A
[Lys(Me1)373]-p53 (368-393), p53 K373(Me1), biotin-labeled, human
Biotin-Lys-Gly-Trp-His-Leu-Lys-Ser-Lys(Me1)-Lys-Gly-Gln-Ser-Thr-Ser-Arg-His-Lys-Lys-Leu-Met-Phe-Lys-Thr-Glu-Gly-Pro-Asp-Ser-Asp-NH2
CANC-009B
[Lys(Me1)373]-p53 (368-393), p53 K373(Me1), biotin-labeled, human
Biotin-Lys-Gly-Trp-His-Leu-Lys-Ser-Lys(Me1)-Lys-Gly-Gln-Ser-Thr-Ser-Arg-His-Lys-Lys-Leu-Met-Phe-Lys-Thr-Glu-Gly-Pro-Asp-Ser-Asp-NH2
CANC-010A
[Lys(Me1)382]-p53 (377-387); p53K382Me1
Thr-Ser-Arg-His-Lys-Lys(Me)-Leu-Met-Phe-Lys-Thr
CANC-011A
[Lys(Me2)370]-p53 (361-380); p53K370Me2
Gly-Ser-Arg-Ala-His-Ser-Ser-His-Leu-Lys(Me2)-Ser-Lys-Lys-Gly-Gln-Ser-Thr-Ser-Arg-His
CANC-011B
[Lys(Me2)370]-p53 (361-380); p53K370Me2
Gly-Ser-Arg-Ala-His-Ser-Ser-His-Leu-Lys(Me2)-Ser-Lys-Lys-Gly-Gln-Ser-Thr-Ser-Arg-His
CANC-012A
[Lys(Me2)372]-p53 (368-393), p53 K372(Me2), biotin-labeled, human
Biotin-Lys-Gly-Gly-His-Leu-Lys-Ser-Lys(Me2)-Lys-Gly-Gln-Ser-Thr-Ser-Arg-His-Lys-Lys-Leu-Met-Phe-Lys-Thr-Glu-Gly-Pro-Asp-Ser-Asp-NH2
CANC-012B
[Lys(Me2)372]-p53 (368-393), p53 K372(Me2), biotin-labeled, human
Biotin-Lys-Gly-Gly-His-Leu-Lys-Ser-Lys(Me2)-Lys-Gly-Gln-Ser-Thr-Ser-Arg-His-Lys-Lys-Leu-Met-Phe-Lys-Thr-Glu-Gly-Pro-Asp-Ser-Asp-NH2
CANC-013A
[Lys(Me2)382]-p53 (377-387); p53K382Me2
Thr-Ser-Arg-His-Lys-Lys(Me2)-Leu-Met-Phe-Lys-Thr
CANC-013B
[Lys(Me2)382]-p53 (377-387); p53K382Me2
Thr-Ser-Arg-His-Lys-Lys(Me2)-Leu-Met-Phe-Lys-Thr
CANC-014A
[Lys(Me3)370]-p53 (361-380); p53K370Me3
Gly-Ser-Arg-Ala-His-Ser-Ser-His-Leu-Lys(Me3)-Ser-Lys-Lys-Gly-Gln-Ser-Thr-Ser-Arg-His
CANC-014B
[Lys(Me3)370]-p53 (361-380); p53K370Me3
Gly-Ser-Arg-Ala-His-Ser-Ser-His-Leu-Lys(Me3)-Ser-Lys-Lys-Gly-Gln-Ser-Thr-Ser-Arg-His
CANC-015A
[Lys(Me3)382]-p53 (377-387); p53K382Me3
Thr-Ser-Arg-His-Lys-Lys(Me3)-Leu-Met-Phe-Lys-Thr
CANC-015B
[Lys(Me3)382]-p53 (377-387); p53K382Me3
Thr-Ser-Arg-His-Lys-Lys(Me3)-Leu-Met-Phe-Lys-Thr
CANC-016A
p53 (17-26)
Glu-Thr-Phe-Ser-Asp-Leu-Trp-Lys-Leu-Leu
CANC-017A
p53 (17-26), FITC labeled
FITC-LC-Glu-Thr-Phe-Ser-Asp-Leu-Trp-Lys-Leu-Leu-NH2
CANC-018A
p53 (361-380)
Gly-Ser-Arg-Ala-His-Ser-Ser-His-Leu-Lys-Ser-Lys-Lys-Gly-Gln-Ser-Thr-Ser-Arg-His
CANC-019A
p53 Tumor Suppressor (361-393), human
Gly-Ser-Arg-Ala-His-Ser-Ser-His-Leu-Lys-Ser-Lys-Lys-Gly-Gln-Ser-Thr-Ser-Arg-His-Lys-Lys-Leu-Met-Phe-Lys-Thr-Glu-Gly-Pro-Asp-Ser-Asp-NH2
CANC-020A
p53 Tumor Suppressor (361-393), LC-Biotin, human
Biotin-LC-Gly-Ser-Arg-Ala-His-Ser-Ser-His-Leu-Lys-Ser-Lys-Lys-Gly-Gln-Ser-Thr-Ser-Arg-His-Lys-Lys-Leu-Met-Phe-Lys-Thr-Glu-Gly-Pro-Asp-Ser-Asp-NH2
CANC-021A
TP53 Q9NP68, p53 Mutant Form (372-389), Lys382 (Ac)
Lys-Lys-Gly-Gln-Ser-Thr-Ser-Arg-His-Lys-Lys(Ac)-Leu-Met-Phe-Lys-Thr-Glu-Gly
Chinese Peptide Updates
30
Nov
2023
Emerging Trends in CGMP Peptide Manufacturing for Therapeutic Breakthroughs
Understanding the Importance of CGMP Peptides in Biopharmaceuticals
Nov 16, 2023
Exhibition review | Chinese Peptide company attended the 3rd China Polypeptide Industry Conference
Oct 11, 2023
The 8th CPC Symposiun on Peptide and Oligonucleotide Therapeutics was successfully concluded
Oct 10, 2023
86-571-86737011
Your browser does not support VBScript!
